News

Health officials are attempting to get ahead of what could be another wave of addiction by issuing a scheduling recommendation for kratom byproduct 7-hydroxymitragynine (also known as 7-OH).
The Food and Drug Administration is considering adding warning labels to antidepressants for people who are pregnant, despite ...
US Health Secretary Robert F. Kennedy Jr., along with Deputy Secretary Jim O’Neill, FDA Commissioner Dr. Marty Makary and Senator Markwayne Mullin, held a press conference to announce urgent new ...
Earlier this month, the U.S. Food and Drug Administration announced that it plans on cracking down on an opioid-like ...
The Trump administration on Tuesday moved to add 7-OH, a psychoactive compound derived from the kratom plant, to the schedule ...
FDA Commissioner Marty Makary said at a press conference Tuesday that scheduling "7-Hydroxymitragynine" (7-OH) kratom extract ...
The U.S. Food and Drug Administration is recommending the scheduling of the 7-OH compound as a controlled substance by the ...
U.S. health officials are cracking down on an opioid-like ingredient being added to drinks, supplements and other products.
FDA Commissioner Marty Makary said at a press conference Tuesday that the federal government is beginning to process to ...
Secretary Robert F. Kennedy Jr. and Food and Drug Administration (FDA) Commissioner Marty Makary will brief reporters Tuesday morning on actions the administration ...
The announcement, on the morning of July 29, 2025, was delivered by HHS Secretary Robert F. Kennedy, Jr. and FDA Commissioner ...
Secretary Kennedy and Commissioner Makary have shown exceptional leadership in confronting one of the most urgent public ...